Elite Pharmaceuticals, Inc.

General ticker "ELTP" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $587.8M (TTM average)

Elite Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 41.9%.

Estimated limits based on current volatility of 2.0%: low 0.52$, high 0.54$

Factors to consider:

  • Total employees count: 64 as of 2024
  • Top business risk factors: Market competition, Supply chain disruptions, Product discontinuation, Market acceptance, Cybersecurity threats
  • Price in estimated range
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [0.26$, 0.65$]
  • 2026-03-31 to 2027-03-31 estimated range: [0.19$, 0.50$]

Financial Metrics affecting the ELTP estimates:

  • Positive: with PPE of -47.2 at the end of fiscal year the price was very low
  • Positive: Operating profit margin, % of 23.32 > 18.64
  • Negative: negative Net income
  • Negative: negative Industry operating cash flow (median)
  • Negative: 0.01 < Interest expense per share per price, % of 0.16
  • Negative: Operating cash flow per share per price, % of 1.51 <= 6.82
  • Negative: negative Industry operating income (median)
  • Negative: 41.86 < Shareholder equity ratio, % of 55.52 <= 63.39

Similar symbols

Short-term ELTP quotes

Long-term ELTP plot with estimates

Financial data

YTD 2024-03-31 2025-03-31
Operating Revenue $56.63MM $84.04MM
Operating Expenses $45.84MM $64.44MM
Operating Income $10.79MM $19.60MM
Non-Operating Income $-10.33MM $-19.65MM
Interest Expense $0.59MM $0.77MM
R&D Expense $6.88MM $7.96MM
Income(Loss) $0.46MM $-0.05MM
Taxes $-19.65MM $4.26MM
Profit(Loss)* $20.11MM $-4.31MM
Stockholders Equity $57.58MM $53.52MM
Inventory $12.93MM $16.24MM
Assets $83.65MM $96.39MM
Operating Cash Flow $-3.28MM $7.46MM
Capital expenditure $0.81MM $2.53MM
Investing Cash Flow $-0.81MM $-2.40MM
Financing Cash Flow $3.39MM $-0.83MM
Earnings Per Share** $0.02 $-0.00

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.